In this article
Layla’s weight-loss page contains monthly, quarterly, and seasonal offer blocks with different figures. That makes the first task identifying which offer is currently attached to the prescription and checkout you are considering.
This guide does not combine those blocks into an invented universal price. It compares alternatives whose payment structures can help you ask clearer questions about the first charge, the regular charge, and the commitment in between.
Resolve the selected offer in writing, including the full initial charge and the regular renewal, before estimating savings elsewhere. CoreAge Rx holds the first sponsored position; that does not establish that it best meets every criterion.
What to know first
- Resolve the selected offer in writing, including the full initial charge and the regular renewal, before estimating savings elsewhere.
- CoreAge Rx is the first listing through a disclosed commercial arrangement.
- Confirm the proposed product, care arrangement, and complete written payment terms.
How this shortlist was selected
CoreAge Rx is number one because it is our featured commercial partner. That position is predetermined by our commercial relationship, and we may earn compensation through its links. Other entries illustrate relevant care and payment models; their order is not a ranking of medication quality, safety, or patient outcomes.
Resolve the selected offer in writing, including the full initial charge and the regular renewal, before estimating savings elsewhere. We used the provider documents linked beside each entry, checked September 21, 2026. We did not purchase treatment, test private accounts, audit every license, or measure response times. The product and current written quote for your own care still need confirmation. Read our review method.
01. CoreAge Rx — featured partner
Our sponsored reference point for a self-pay offer. Its quoted term and total need the same verification as a Layla promotion.
The current sale page advertises semaglutide from $99 per month and tirzepatide from $149 per month, with no membership fee. Those are advertised starting figures, not a personalized checkout quote. The plan length and total amount due must be read alongside the monthly equivalent.
The sale page says CoreAge works with U.S. compounding pharmacies and describes 503A facilities. A category of pharmacy is not a substitute for the name, address, and state license of the pharmacy filling your own prescription. Request that information before deciding.
Continue with our CoreAge Rx review and pricing details.
02. NiceRx
Publishes the introductory and continuing prices separately. It is useful when the main goal is a clearer view of the second and later payments.
NiceRx lists semaglutide at $99 for the first month, then $199 per month, and tirzepatide at $199 for the first month, then $299. It says medication, provider access, and shipping are included.
Budget with the ongoing price, not just the first month. The page directs cancellation requests to email and says dispensed medication cannot be returned; confirm the order stage and next renewal separately.
Check the official NiceRx program page for the current offer and conditions. Our NiceRx alternatives comparison examines other care models.
03. Brightmeds
Has a dated campaign with explicit single-month and three-month prices. Confirm the campaign remains available rather than assuming a seasonal page controls checkout.
The Brightmeds Summer Special page lists semaglutide at $297 for three months ($99 per month), or $129 for a single month. Tirzepatide is $357 for three months ($119 per month), or $149 for a single month. These are dated campaign offers.
Confirm whether the campaign remains available for your prescription and what the renewal costs. The three-month equivalent is not the charge for the separately listed single-month option.
Check the official Brightmeds program page for the current offer and conditions. Our Brightmeds alternatives comparison examines other care models.
04. Yucca Health
Lists monthly and six-month options side by side. Compare the selected commitment rather than choosing whichever displayed equivalent is smallest.
Yucca lists semaglutide at $125 per month on a six-month plan totaling $750, or $146 month to month. Tirzepatide is listed at $225 per month on a six-month plan totaling $1,350, or $258 month to month.
The $125 headline is a prepaid-plan equivalent, not the monthly-plan charge. Keep the selected term, renewal price, and cancellation policy with the purchase summary.
Check the official Yucca Health program page for the current offer and conditions. Our Yucca Health alternatives comparison examines other care models.
05. OrderlyMeds
Distinguishes starter treatment from later care. Confirm whether an existing GLP-1 patient qualifies for the advertised new-customer package.
The pricing page advertises a two-month starter package at $149 total for compounded semaglutide and $299 total for compounded tirzepatide. Those totals correspond to $74.50 and $149.50 per month, even though the display rounds the monthly headlines. The offer is labeled for new customers.
OrderlyMeds describes text-based provider review and pharmacy preparation after approval. Its stated shipping time is an estimate and should not be confused with guaranteed prescribing or a tested turnaround time.
Continue with our OrderlyMeds review and pricing details.
06. Coby Health
A comparison with monthly and longer plans and explicit pharmacy-stage cancellation limits. Ask for the complete recurring quote because the homepage does not settle every price.
Coby Health offers monthly and multi-month compounded GLP-1 plans and says there are no membership fees. The homepage reviewed did not provide a single complete dollar quote applicable to every plan.
Its policy describes a $50 visit-and-clinical fee deduction if a pre-pharmacy cancellation is successfully processed. Once a prescription reaches a pharmacy, changes are restricted; cancelling future renewals is a separate issue.
Check the official Coby Health program page for the current offer and conditions.
The current Layla baseline
Layla’s weight-loss page contains several offer blocks: monthly semaglutide at $297, monthly tirzepatide at $449, and other introductory or quarterly offers. The blocks do not establish one unambiguous ongoing price for every plan.
Layla describes online assessment, consultation, medication, and shipping within its plans, with ongoing medical support and no insurance required.
Request a written checkout summary identifying the current promotion, total upfront payment, regular refill price, and cancellation cutoff. Do not combine figures from different seasonal, monthly, or quarterly offer blocks.
The details that decide this comparison
Ask which dated promotion applies and whether it is limited to a first month or a quarterly purchase. Save the plan-specific terms rather than relying on a homepage banner.
Request the total amount charged today and the date and amount of the next payment. A monthly equivalent can conceal a larger upfront charge.
Confirm whether cancellation stops only the next renewal or can affect an unprocessed order. “Cancel anytime” does not establish a refund for medication already dispensed.
Keep the treatment distinction clear
An FDA-approved branded medicine and a compounded preparation have different regulatory status. Compounded drugs are not FDA-approved. Trials of an approved product do not prove that every compounded version has the same performance.
Ask the prescribing professional why the exact product is appropriate for you, and identify the dispensing pharmacy. A price, a website’s appearance, or a place in this list cannot establish personal suitability. Our guide to compounded drugs and FDA approval explains the distinction.
Before you make a change
If the written checkout summary and the page disagree, ask the provider to explain which terms govern before paying. Keep both records with your receipt.
For an existing patient, compare the next clinically appropriate refill rather than starting the calculation from a new-user package that may not apply.
Sources & research notes
Checked September 21, 2026. Provider pages document the provider’s own statements; they do not independently establish treatment safety or results. This is desk research, not a product test or clinical review.
- CoreAge Rx: official treatment overviewProvider-published information · Checked September 21, 2026
- CoreAge Rx: current sale offerProvider-published information · Checked September 21, 2026
- CoreAge Rx: plan billing explainedProvider-published information · Checked September 21, 2026
- CoreAge Rx: contact and professional-entity disclosuresProvider-published information · Checked September 21, 2026
- CoreAge Rx: purchasing processProvider-published information · Checked September 21, 2026
- NiceRx: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
- Brightmeds: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
- Yucca Health: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
- No Insurance GLP-1 and GLP-1/GIP Medication Cost CalculatorProvider-published information · Checked September 21, 2026
- Coby Health: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
- Layla: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
- FDA: concerns with unapproved GLP-1 drugsRegulatory / public agency · Checked September 21, 2026
- FDA: risks of compounded drugsRegulatory / public agency · Checked September 21, 2026
Read our methodology · Commercial disclosure · Request a correction